1
|
Multiple Correspondence Analysis on Amino Acid Properties within the Variable Region of the Capsid Protein Shows Differences between Classical and Virulent Systemic Feline Calicivirus Strains. Viruses 2019; 11:v11121090. [PMID: 31771183 PMCID: PMC6950066 DOI: 10.3390/v11121090] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 11/18/2019] [Accepted: 11/19/2019] [Indexed: 01/20/2023] Open
Abstract
Feline calicivirus (FCV) is a widespread and highly prevalent pathogen of domestic cats, responsible for mild upper respiratory tract disease. Outbreaks of severe virulent systemic disease (VSD) associated with FCV infection have been reported worldwide. VSD FCV strains have a broader tropism and cause a systemic vascular compromise. Despite clear differences in the pathogenesis of VSD and oral respiratory infections, attempts to identify specific molecular markers of VSD strains on the major capsid protein VP1 have failed. Region E of VP1 is responsible for the interaction with the cell receptor Junctional Adhesion Molecule JAM-1 (FeJAM-1) and with VP2 minor capsid protein during the entry of the virus. We carried out an original analysis on the sequences from region E of VSD and classical strains. A Multiple Correspondence Analysis was performed on a Boolean matrix built by coding sequences on the basis of their amino acid properties. For the first time, this approach was able to differentiate VSD and classical FCV. Seven remarkable residue positions were shown to be statistically significant for pathotype differentiation, mainly located in the N-terminal hypervariable part of region E. As structural analysis suggested an interaction of these residues with FeJAM-1 or VP2, post-binding events, and specific conformational changes may explain the difference of pathogenesis between pathotypes.
Collapse
|
2
|
Sato H, Sehata G, Okada N, Iwamoto K, Masubuchi K, Kainuma R, Noda T, Igarashi T, Sawada T, Noro T, Oishi E. Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats. J Gen Virol 2017; 98:1730-1738. [PMID: 28691897 DOI: 10.1099/jgv.0.000827] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The protective efficacy of intranasal (IN) administration of inactivated feline calicivirus (FCV) vaccine against homologous or heterologous FCV infection was investigated. Groups of cats immunized with the experimental inactivated, non-adjuvanted FCV vaccine via either the IN or subcutaneous (SC) route were exposed to homologous or highly heterologous FCV. Both the IN and SC immunization protocols established robust protection against homologous FCV infection. Although neither immunization regimen conferred protection against the heterologous strain, clinical scores and virus titres of oral swabs were lower in cats in the IN group compared to those in the SC group, accompanying a faster neutralizing antibody response against the heterologous virus in cats in the IN group. The IN group secreted more IgA specific to FCV proteins in oral washes (lavage fluids from the oral cavity) than the SC group. IN immunization with an inactivated whole FCV particle, which protects cats from homologous virus exposure and shortens the period of heterologous virus shedding, may serve as a better platform for anti-FCV vaccine.
Collapse
Affiliation(s)
- Hiroaki Sato
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Go Sehata
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Nobutaka Okada
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Kayo Iwamoto
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Katsuo Masubuchi
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Risa Kainuma
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Tatsuki Noda
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Tatsuhiko Igarashi
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Takuo Sawada
- Laboratory of Veterinary Microbiology, Nippon Veterinary and Life Science University, Musashino, Tokyo 180-8602, Japan
| | - Taichi Noro
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| | - Eiji Oishi
- Kyoto Biken Laboratories, Inc., 24-16 Makishima-cho, Uji-shi, Kyoto 611-0041, Japan
| |
Collapse
|
3
|
Reynolds BS, Poulet H, Pingret JL, Jas D, Brunet S, Lemeter C, Etievant M, Boucraut-Baralon C. A nosocomial outbreak of feline calicivirus associated virulent systemic disease in France. J Feline Med Surg 2009; 11:633-44. [PMID: 19201637 PMCID: PMC11132575 DOI: 10.1016/j.jfms.2008.12.005] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2008] [Indexed: 11/15/2022]
Abstract
This report describes a nosocomial outbreak of feline calicivirus (FCV) associated virulent systemic disease (VSD) in a French veterinary teaching hospital in 2005. The outbreak started in March and resolved within 1 month. Signs, clinical course, clinicopathological findings and lesions were typical of FCV-induced VSD. FCV infection was confirmed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Among the eight infected cats, two had to be euthanased, three died, and three recovered after medical treatment. Virus could not be confined inside the animal hospital and on two occasions, students' own cats became infected. Subsequent genetic sequencing studies confirmed that the eight cats were infected with the same strain of virus, and that it was distinct from those involved in the US and UK outbreaks of VSD. Virulence and viral excretion patterns of the isolated strain were further characterised by experimental infection.
Collapse
Affiliation(s)
- Brice S Reynolds
- Department of Clinical Sciences, National Veterinary School of Toulouse, 23 chemin des Capelles, BP 87614, 31076 Toulouse cedex 03, France.
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Pesavento PA, Chang KO, Parker JSL. Molecular virology of feline calicivirus. Vet Clin North Am Small Anim Pract 2008; 38:775-86, vii. [PMID: 18501277 DOI: 10.1016/j.cvsm.2008.03.002] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Caliciviridae are small, nonenveloped, positive-stranded RNA viruses. Much of our understanding of the molecular biology of the caliciviruses has come from the study of the naturally occurring animal caliciviruses. In particular, many studies have focused on the molecular virology of feline calicivirus (FCV), which reflects its importance as a natural pathogen of cats. FCVs demonstrate a remarkable capacity for high genetic, antigenic, and clinical diversity; "outbreak" vaccine resistant strains occur frequently. This article updates the reader on the current status of clinical behavior and pathogenesis of FCV.
Collapse
Affiliation(s)
- Patricia A Pesavento
- Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, One Shields Avenue, 4206 VM3A, Davis, CA 95616-5270, USA.
| | | | | |
Collapse
|
5
|
Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: Relation between in vitro cross-neutralization and heterologous protection in vivo. Vaccine 2008; 26:3647-54. [DOI: 10.1016/j.vaccine.2008.04.082] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2008] [Revised: 04/10/2008] [Accepted: 04/28/2008] [Indexed: 11/19/2022]
|